NEW YORK (GenomeWeb News) — The US Food and Drug Administration will review a Roche Diagnostics test designed to diagnose HIV and hepatitis infections in donated blood and plasma, Roche said Wednesday.
 
The cobas TaqScreen MPX test is a real-time PCR-based single-multiplex assay that if approved would be used to detect HIV types 1 and 2 and hepatitis viruses C and B.
 
The tests would function on Roche’s cobas s 201 platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.